
Divog 0.3mg Tablet
Marketer
Canipla Care
Salt Composition
Voglibose (0.3mg)
Overview Divog 0.3mg Tablet
Glyconia 0.3mg tablets are prescribed for the management of type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (elevated blood sugar after meals). It's indicated when dietary modifications and other comparable medications prove insufficient in controlling blood glucose levels. Glyconia 0.3mg tablets should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Abrupt cessation requires medical consultation, as it may lead to dangerously elevated blood glucose, potentially resulting in severe complications such as renal impairment and visual loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include flatulence, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Glyconia 0.3mg tablets alone do not cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Hypoglycemic episodes necessitate the ingestion of pure glucose; sucrose or other common sugars may be ineffective. Prior to commencing treatment, inform your doctor of any hepatic or renal conditions. This medication is contraindicated in patients with bowel ulceration or inflammation (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should consult their physician before use. Disclose all other medications to your doctor to ensure medication safety. Limit alcohol consumption, as it can heighten the risk of hypoglycemia.
Uses of Divog 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Divog 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Divog 0.3mg Tablet should be administered on an empty stomach.
Common Side effects of Divog 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Divog 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Divog tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
How Divog 0.3mg Tablet works:
Divog 0.3mg tablets are used to manage diabetes. They work by blocking the enzymes in the intestines that digest complex carbohydrates into simpler sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Divog 0.3mg Tablets should not be taken together due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Divog 0.3mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, Divog 0.3mg tablets appear to pose minimal breastfeeding risk. Studies in humans indicate negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Divog 0.3mg tablets.
KidneyCAUTION
For individuals with severely impaired kidney function, the use of Divog 0.3mg tablets requires careful consideration. Dosage modification of Divog 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Divog 0.3mg tablets cautiously. Dosage modification for Divog 0.3mg tablets may be necessary; physician consultation is advised.
What if you forget to take Divog 0.3mg Tablet :
Omit any missed Divog 0.3mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Divog 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
